0R15 9025.0 0.0% 0R1E 9410.0 0.0% 0M69 None None% 0R2V 247.99 9682.643% 0QYR 1567.5 0.0% 0QYP 439.3701 -2.9016% 0RUK None None% 0RYA 1597.0 1.2682% 0RIH 195.55 0.0% 0RIH 191.4 -2.1222% 0R1O 225.5 9683.0803% 0R1O None None% 0QFP 10475.8496 107.8542% 0M2Z 252.573 0.2373% 0VSO 33.0 -7.3164% 0R1I None None% 0QZI 622.0 0.0% 0QZ0 220.0 0.0% 0NZF None None% 0YXG 222.05 -4.1318%

US Equities Report

Zoetis Inc

Sep 01, 2022

ZTS
Investment Type
Large-cap
Risk Level
Action
Rec. Price ()

 

Section 1: Company Overview and Fundamentals

  • Company Overview:

The company Zoetis Inc. focuses on the research, development, production, and marketing of drugs, vaccines, diagnostic tools, biotechnological devices, genetic testing, and precision animal health technologies. The company operates a business that involves the commercialization of products for eight core species, including cattle, swine, poultry, fish, sheep, dogs, cats, and horses and cattle, swine, and pigs. The company also sells products in the areas of dermatology, anti-infectives, parasiticides, vaccines, and other pharmaceuticals, as well as medicated feed additives and animal health diagnostics.

1.2 The Key Positives, Negatives, and Investment summary

1.3 Key Metrics:

The graphs below demonstrate the rising trend in the company's sales, gross profits, and gross profit margin, due to increased demand for the company’s products as well as increased efficiency in lowering the cost of revenues by the company. Furthermore, the company has grown its revenues and gross profit at an impressive 5-year CAGR rate of 9.73% and 11.04% respectively.

1.4 Top 10 shareholders:

  • The top 10 shareholders together form ~34.93% of the total shareholding, signifying consolidating shareholding. The Vanguard Group Inc and BlackRock Institutional Trust Company are the biggest shareholders, holding the maximum stake in the company at ~7.74% and ~4.98%, respectively.

Section 2: Business Updates and Financial Highlights

2.1 Recent Updates:

The below picture gives an overview of the recent updates:

 2.2 Insights of Q2FY22:

Section 3: Key Risks and Outlook

Section 4: Stock Recommendation Summary:

4.1 Price Performance and Technical Summary:

4.2 Fundamental Valuation

Valuation Methodology: EV/Sales Multiple Based Relative Valuation

Markets are trading in a highly volatile zone currently due to certain macro-economic and geopolitical tensions prevailing. Therefore, it is prudent to follow a cautious approach while investing.

Note 1: The reference data in this report has been partly sourced from REFINITIV.

Note 2: Investment decisions should be made depending on an individual's appetite for upside potential, risks, holding duration, and any previous holdings. An 'Exit' from the stock can be considered if the Target Price mentioned as per the Valuation and or the technical levels provided has been achieved and is subject to the factors discussed above.

Note 3: The report publishing date is as per the Pacific Time Zone.

Technical Indicators Defined: -

Support: A level at which the stock prices tend to find support if they are falling, and a downtrend may take a pause backed by demand or buying interest. Support 1 refers to the nearby support level for the stock and if the price breaches the level, then Support 2 may act as the crucial support level for the stock.

Resistance: A level at which the stock prices tend to find resistance when they are rising, and an uptrend may take a pause due to profit booking or selling interest. Resistance 1 refers to the nearby resistance level for the stock and if the price surpasses the level, then Resistance 2 may act as the crucial resistance level for the stock.

Stop-loss: It is a level to protect further losses in case of unfavorable movement in the stock prices.


 

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions